Lysophospholipid–TRPV1 interactions in chemotherapy-induced neuropathy
Open Access
- 26 August 2026
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (35)
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is a common and dose-limiting side effect of first-line chemotherapeutics such as paclitaxel, for which effective treatments are currently unavailable. We found that plasma collected 24 h after paclitaxel administration enhanced sensory neuron activation. To identify potential mediators of this effect, we applied a broad LC-HRMS-based lipidomics approach to quantify plasma lipids in breast cancer patients before and 24 h after treatment. We observed significant elevations in lysophospholipids with 18:1 fatty acid chain, especially lysophosphatidylcholine (LPC) and lysophosphatidylglycerol (LPG) after paclitaxel treatment. Assessing their activity on sensory neurons revealed that these unsaturated lysophospholipids, but not their saturated counterparts, activated the transient receptor potential vanilloid 1 (TRPV1) channel, a key mediator of nociception. To investigate TRPV1–LPL interactions, we combined molecular dynamics simulations with targeted mutagenesis. Unlike LPC, which is zwitterionic due to its choline headgroup, LPG carries a negative charge and contains a glycerol headgroup instead. As a result of lacking a positive countercharge in its headgroup, LPG adopts a more tilted orientation within the vanilloid binding pocket (VBP) and forms stronger interactions with residues S510 and S512. Overall, the agonist’s potency appears to depend on its interaction with and proximity to Y511, which was confirmed through electrophysiological recordings and calcium imaging using mutated hTRPV1 channels. These findings reveal lipid–channel interactions and provide mechanistic insight into endogenous lipid modulation of pain signaling in the context of paclitaxel-induced CIPN.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (445757098)
- Deutsche Forschungsgemeinschaft (528562393)
- Deutsche Forschungsgemeinschaft (450648163)
- Hessisches Ministerium für Wissenschaft und Kunst (LOEWE/2/18/519/03/11.001(0005)/124 Lipid Space)
- Fraunhofer Cluster of Excellence Immune-Mediated Diseases (Project: Neuropathic Pain)
This publication has 58 references indexed in Scilit:
- Targeting TRP channels for pain relief: A review of current evidence from bench to bedsideCurrent Opinion in Pharmacology, 2024
- Pre-analytical sample handling standardization for reliable measurement of metabolites and lipids in LC-MS-based clinical researchJournal of Mass Spectrometry and Advances in the Clinical Lab, 2023
- The mechanisms of lysophosphatidylcholine in the development of diseasesLife Sciences, 2020
- Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systemsExperimental Neurology, 2020
- Targeted lipidomics reveal derangement of ceramides in major depression and bipolar disorderMetabolism, 2019
- Capsaicin Interaction with TRPV1 Channels in a Lipid Bilayer: Molecular Dynamics SimulationBiophysical Journal, 2015
- Lysophosphatidic acid (LPA) and its receptors: Role in airway inflammation and remodelingBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2013
- Lysophosphatidic acid: Chemical signature of neuropathic painBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2013
- MDAnalysis: A toolkit for the analysis of molecular dynamics simulationsJournal of Computational Chemistry, 2011
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996